Review of palonosetron: emerging data distinguishing it as a novel 5-HT₃ receptor antagonist for chemotherapy-induced nausea and vomiting

By Saito Mitsue   Tsukuda Mamoru  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 6, 2010-04 ,pp. : 1003-1014

Informa Healthcare

Access to resources Recommend Favorite

Palonosetron: a unique 5-HT3-receptor antagonist for the prevention of chemotherapy-induced emesis

By Grunberg Steven M   Koeller James M  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2297-2303

Informa Healthcare

Access to resources Recommend Favorite

LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine 2A receptor antagonist: a comparison with the antidepressant, nefazodone

By Pullar I.A.   Carney S.L.   Colvin E.M.   Lucaites V.L.   Nelson D.L.   Wedley S.  

European Journal of Pharmacology, Vol. 407, Iss. 1, 2000-10 ,pp. : 39-46

Elsevier

Access to resources Recommend Favorite

Effect of a Novel 5-Hydroxytryptamine 3 (5-HT 3 ) Receptor Antagonist, GK-128, on 5-HT 3 Receptors Mediating Contractions and Relaxations in Guinea-Pig Distal Colon

By Ito C.   Kawamura R.   Isobe Y.   Tsuchida K.   Muramatsu M.   Higuchi S.  

General Pharmacology, Vol. 29, Iss. 3, 1997-09 ,pp. : 353-359

Elsevier

Access to resources Recommend Favorite

Relationship Between the 5-HT₃ Receptor Pharmacophore and the Conformations of 5-Hydroxytryptamine

By Daveu C.   Bureau R.   Rault S.  

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 2, 2000-02 ,pp. : 73-76

Pharmaceutical Press

Access to resources Recommend Favorite